Joseph E. McClellan
Chief Tech/Sci/R&D Officer at ALVOTECH
Net worth: - $ as of 30/04/2024
Profile
Joseph E.
McClellan is currently the Chief Scientific Officer at Alvotech hf and Alvotech.
Previously, he worked at Pfizer Inc. as the Global Head-Biosimilars Development & Medicine.
McClellan completed his undergraduate degree at the College of the Holy Cross (Massachusetts), his doctorate at the University of Florida, and his MBA at Northeastern University (China).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALVOTECH
-.--% | 15/02/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Joseph E. McClellan active positions
| Companies | Position | Start |
|---|---|---|
| ALVOTECH | Chief Tech/Sci/R&D Officer | 01/10/2019 |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Chief Tech/Sci/R&D Officer | 01/10/2019 |
Former positions of Joseph E. McClellan
| Companies | Position | End |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
Training of Joseph E. McClellan
| University of Florida | Doctorate Degree |
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
| Northeastern University (China) | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ALVOTECH | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Health Technology |
- Stock Market
- Insiders
- Joseph E. McClellan